Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 2
2006 2
2007 3
2008 1
2009 2
2011 1
2013 1
2014 3
2015 2
2016 3
2018 2
2019 3
2020 2
2021 3
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Melatonin receptor ligands: A pharmaco-chemical perspective.
Boutin JA, Witt-Enderby PA, Sotriffer C, Zlotos DP. Boutin JA, et al. Among authors: zlotos dp. J Pineal Res. 2020 Oct;69(3):e12672. doi: 10.1111/jpi.12672. Epub 2020 Jul 5. J Pineal Res. 2020. PMID: 32531076 Review.
Drug conjugates-an emerging approach to treat breast cancer.
Hasan M, Leak RK, Stratford RE, Zlotos DP, Witt-Enderby PA. Hasan M, et al. Among authors: zlotos dp. Pharmacol Res Perspect. 2018 Jul 5;6(4):e00417. doi: 10.1002/prp2.417. eCollection 2018 Jul. Pharmacol Res Perspect. 2018. PMID: 29983986 Free PMC article. Review.
Update on melatonin receptors: IUPHAR Review 20.
Jockers R, Delagrange P, Dubocovich ML, Markus RP, Renault N, Tosini G, Cecon E, Zlotos DP. Jockers R, et al. Among authors: zlotos dp. Br J Pharmacol. 2016 Sep;173(18):2702-25. doi: 10.1111/bph.13536. Epub 2016 Aug 8. Br J Pharmacol. 2016. PMID: 27314810 Free PMC article. Review.
Recent advances in melatonin receptor ligands.
Zlotos DP. Zlotos DP. Arch Pharm (Weinheim). 2005 Jun;338(5-6):229-47. doi: 10.1002/ardp.200400996. Arch Pharm (Weinheim). 2005. PMID: 15952241 Review.
Gefitinib-Tamoxifen Hybrid Ligands as Potent Agents against Triple-Negative Breast Cancer.
Abdelmalek CM, Hu Z, Kronenberger T, Küblbeck J, Kinnen FJM, Hesse SS, Malik A, Kudolo M, Niess R, Gehringer M, Zender L, Witt-Enderby PA, Zlotos DP, Laufer SA. Abdelmalek CM, et al. Among authors: zlotos dp. J Med Chem. 2022 Mar 24;65(6):4616-4632. doi: 10.1021/acs.jmedchem.1c01646. Epub 2022 Mar 14. J Med Chem. 2022. PMID: 35286086
37 results